手术机器人等医疗服务有了“明码标价”

Core Viewpoint - The National Healthcare Security Administration (NHSA) has released a guideline to standardize pricing for surgical and treatment auxiliary services, establishing 37 pricing items and promoting the clinical application of advanced technologies like 3D printing and surgical robots [1][2]. Group 1: Pricing Guidelines and Impact - The guideline includes a pricing project for 3D bioprinting to facilitate the transition from concept testing to clinical application, which is expected to help companies in the sector [2][3]. - The guideline addresses the pricing for surgical robots, categorizing them based on their involvement in surgeries and clinical value, with a coefficient-based charging model linked to the main surgery [3][4]. - The NHSA will guide local authorities to establish reasonable pricing standards, ensuring a balance between cost-sharing for surgical robots and patient accessibility [5]. Group 2: Industry Development and Innovation - The release of the guideline is anticipated to boost the enthusiasm for research and development among domestic companies, shortening the promotion cycle for new technologies and driving down costs in the domestic supply chain [7]. - The guideline aims to resolve clinical translation issues for innovative technologies like surgical navigation and robots, benefiting both patients and the medical equipment industry [7]. - A new pricing project for remote surgical assistance has been established to facilitate the provision of high-quality medical resources across regions, reducing the burden on patients seeking care away from home [7]. Group 3: Technological Advancements - The first successful remote surgery over a distance of 8,000 kilometers was performed using a domestic surgical robot, showcasing the potential of remote surgical capabilities [9]. - The market share of domestic laparoscopic surgical robots is projected to grow from 32.61% in 2023 to 48.89% in 2024, indicating significant growth potential in the sector [9].